Antimutagenic effects of amifostine: Clinical implications

Seminars in Oncology

Volumn 23, Issue 4 SUPPL. 8, 1996, Pages 53-57

  Kataoka, Y ^a   Perrin, J ^a   Hunter, N ^a   Milas, L ^a   Grdina, D J ^a  

^a ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; ANTIMUTAGENIC AGENT; CYCLOPHOSPHAMIDE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ANTINEOPLASTIC ACTIVITY; CELL KILLING; CONFERENCE PAPER; FIBROSARCOMA; GENE MUTATION; MUTAGENESIS; MUTATION RATE; PRIORITY JOURNAL; TUMOR CELL CULTURE;

AMIFOSTINE; ANIMALS; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; HUMANS; MALE; MICE; MICE, INBRED C3H; MUTAGENESIS; RADIATION-PROTECTIVE AGENTS;

EID: 0029762414     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)